News
About This EventTvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in ...
About This EventWebull Corporation (Nasdaq: BULL), the owner of leading online investment platform, Webull, visits the Nasdaq MarketSite in Times Square to celebrate its recent public listing.In honor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback